z-logo
Premium
C‐reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy
Author(s) -
Coimbra S,
Oliveira H,
Reis F,
Belo L,
Rocha S,
Quintanilha A,
Figueiredo A,
Teixeira F,
Castro E,
RochaPereira P,
SantosSilva A
Publication year - 2010
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/j.1468-3083.2009.03527.x
Subject(s) - psoriasis , medicine , lactoferrin , psoriasis area and severity index , elastase , c reactive protein , immunology , neutrophil elastase , gastroenterology , dermatology , inflammation , enzyme , biochemistry , chemistry , genetics , biology
Background  Psoriasis vulgaris is a chronic recurrent inflammatory skin disease and psoriatic lesions have shown leucocyte infiltration. Objectives  We aimed to study C‐reactive protein (CRP) and leucocyte activation markers/inhibitors as potential monitors of psoriasis vulgaris . Methods  A cross‐sectional ( n  = 73) and a longitudinal study (before, at 3, 6 and 12 weeks of therapy; n  = 47) was performed; 10 patients started topical treatment, 17 narrow‐band ultraviolet light B (NBUVB) and 20 psolaren associated to UVA (PUVA); psoriasis severity was defined by Psoriasis Area and Severity Index (PASI). Results  Compared with control ( n  = 38), we found higher CRP levels, total leukocyte/neutrophil count, elastase, lactoferrin and α1‐antitrypsin. Increasing PASI was linked to increasing CRP and a trend to higher elastase and lactoferrin, suggesting that worsening enhances inflammatory response with neutrophil activation. CRP correlated with PASI, total leucocytes, neutrophils, elastase, lactoferrin and α1‐antitrypsin. NBUVB and PUVA presented similar effects. Conclusion  We propose CRP as a useful marker of psoriasis severity that could be used to monitor psoriasis and its treatment, and, together with PASI and elastase, could also be used as a global index of severity.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here